BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36965889)

  • 21. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
    Li L; Leng J; Jia S; Lang J
    Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
    Zhang P; Song K; Li L; Yukuwa K; Kong B
    Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
    Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
    Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.
    Hai N; Hou Q; Guo R
    Int J Hyperthermia; 2021; 38(1):65-69. PubMed ID: 33472465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.
    Zhang H; Cao B; Tong J; Guo J; Zheng J; Zhu L; Niu Z; Chen L
    BMC Womens Health; 2022 Nov; 22(1):451. PubMed ID: 36384588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
    Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
    Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
    Lv N; Guo J; Yuan Q; Shen S; Chen Q; Tong J
    J Minim Invasive Gynecol; 2024 Jan; 31(1):57-63. PubMed ID: 37838016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
    Heikinheimo O; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of modified subtotal resection of adenomyosis combined with LNG-IUS and GnRH-a sequential therapy in severe adenomyosis: A case series.
    Qin Z; Dong Z; Tang H; Zhang S; Wang H; Bao M; Wei W; Shi R; Chen J; Xia B
    Front Surg; 2022; 9():914725. PubMed ID: 36061067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
    Papadakis EP; El-Nashar SA; Laughlin-Tommaso SK; Shazly SA; Hopkins MR; Breitkopf DM; Famuyide AO
    J Minim Invasive Gynecol; 2015; 22(7):1203-7. PubMed ID: 26122898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.
    Conz L; Mota BS; Bahamondes L; Teixeira Dória M; Françoise Mauricette Derchain S; Rieira R; Sarian LO
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):970-982. PubMed ID: 31990981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
    Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
    J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
    Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
    Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
    Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Liu ZZ; You SS; Chang XY; Lang YH
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2415-20. PubMed ID: 27545034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.